TITLE

News

AUTHOR(S)
Kaya, Donald
PUB. DATE
July 2003
SOURCE
Clinical Infectious Diseases;7/15/2003, Vol. 37 Issue 2, pI
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Presents news briefs related to medicine as of July 15, 2003. Approval of rapid assay for aspergillus antigen by the U.S. Food and Drug Administration; Symposium at New York Academy of Sciences on severe acute respiratory syndrome as of May 19, 2003.
ACCESSION #
10361786

 

Related Articles

  • Message From the President. McGee, Leslie // American Acupuncturist;Summer2007, Vol. 40, p5 

    The article focuses on the developments in the American Association of Acupuncture and Oriental Medicine (AAAOM). It has collaborated with other organizations to promote acupuncture as a profession. It notes that AAAOM has been challenging the U.S. Food and Drug Administration (FDA) regulation...

  • Politics Versus Science. Wechsler, Jill // Pharmaceutical Technology;Jul2004, Vol. 28 Issue 7, p24 

    The U.S. Food & Drug Association (FDA) held its tenth annual Science Forum to highlight the work of agency researchers. The association also discussed its regulatory decisions. FDA's new Critical Path Initiative, which aims to spur more-efficient drug development provided a focal point for...

  • FDA Holds Public Meeting on GE Salmon. Cameron, Shannon // FDA Veterinarian;Dec2010, Issue 3, p1 

    Information regarding the Veterinary Medicine Advisory Committee (VMAC) meeting on the application to approve AquAdvantage Salmon, organized by the U.S. Food and Drug Administration (FDA) on September 19-20, 2010 is presented. Topics include the production information of genetically engineered...

  • Comparison of QTc Data Analysis Methods Recommended by the ICH E14 Guidance and Exposure-Response Analysis: Case Study of a Thorough QT Study of Asenapine. Chapel, S.; Hutmacher, M. M.; Bockbrader, H.; de Greef, R.; Lalonde, R. L. // Clinical Pharmacology & Therapeutics;Jan2011, Vol. 89 Issue 1, p75 

    An assessment of the effects of asenapine on QTc interval in patients with schizophrenia revealed a discrepancy between the results obtained by two different methods: an intersection-union test (IUT) (as recommended in the International Conference on Harmonisation E14 guidance) and an...

  • Industry Calendar.  // BioPharm International;Aug2006, Vol. 19 Issue 8, p78 

    The article presents a calendar of events related to the pharmaceutical industry for 2006. The Parenteral Drug Association and the U.S. Food and Drug Administration will conduct a joint regulatory conference in September 11-14 in Washington D.C. An international conference on modern vaccines...

  • FOSTERING THE CRITICAL PATH INITIATIVE.  // FDA Consumer;Sep/Oct2006, Vol. 40 Issue 5, p31 

    The article focuses on the critical path initiative of the U.S. Food and Drug Administration. The initiative aims to bring medical discoveries to patients faster by modernizing product development. Key features of the Critical Path to New Medical Products: The Challenges in Protecting Human...

  • Intellectual Property - Summary of June 2008 FDA Public Meeting.  // Venulex Legal Summaries;2008 Q3, Special section p1 

    The article discusses the highlights of a public meeting held by the U.S. Food and Drug Administration (FDA) from June 5 to 6, 2008 to discuss a paper that describes the logistics of the pilot program to reduce medication errors caused by look-alike and sound-alike proprietary names. Topics...

  • FDA Warms to Pathway Tool Use. Russell, John // Bio-IT World;May2008, Vol. 7 Issue 4, p38 

    The article discusses the highlights of a speech delivered by Frederico Goodsaid of the U.S. Food and Drug Administration (FDA) during the annual "Molecular Medicine Tri-Conference" of the Cambridge Healthtech Institute. He explains the evolving Voluntary Exploratory Data Submissions (VXDS)...

  • Circulatory systems panel slates 2 meetings.  // Medical Device Daily;8/1/2007, Vol. 11 Issue 145, p9 

    The article offers information on the meetings to be held by the circulatory systems advisory committee of the U.S. Food and Drug Administration on September 19 and 20, 2007.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics